Connaissances Accueil Santé humaine Connaissances All Avis Exposés Science populaire Entretiens Filtrer Therapeutic areasCOVID-19Santé digestive Apply Accueil Santé humaine Connaissances RBDCOV Talks HIPRA’s participation: In 5 minutes, what is a recombinant protein vaccine? Accueil Santé humaine Connaissances RBDCOV: The project’s origins and future endeavours Accueil Santé humaine Connaissances Humoral immune response against XBB.1.5 and BQ.1.1 SARS-CoV-2 variants of a fourth dose of PHH-1V vaccine in adult subjects Accueil Santé humaine Connaissances Reactogenicity of third and fourth booster doses of HIPRA PHH-1V, a bivalent recombinant protein vaccine against SARS-CoV-2 Accueil Santé humaine Connaissances Humoral immune response against SARS-CoV-2 variants of PHH-1V booster vaccine in subjects previously vaccinated with a mRNA vaccine Accueil Santé humaine Connaissances One-year humoral response of PHH-1V booster vaccine in subjects previously vaccinated against COVID-19 with a mRNA vaccine Accueil Santé humaine Connaissances Dr. Àlex Soriano (Hospital Clínic de Barcelona): "Public-private collaboration is essential to achieve significant scientific advances" Accueil Santé humaine Connaissances Update on BIMERVAX® immunogenicity amplitude. Insights on humoral response against XBB.1.5 from an extension study Accueil Santé humaine Connaissances Alicante-Winter Immunology Symposium in Health (A-Wish) and the Boulle-SEI awards Charger plus
